Research Article
Modeling the Effects of Nonpharmaceutical Interventions on COVID-19 Spread in Kenya
Table 1
Parameters of the SEIR model of COVID-19.
| | Model parameter name | Symbol | Value | References |
| | Rate of infection from the asymptomatic cases (A) | | 4.0 | Estimated | | Rate of infection from the mild cases (M) | | 2.667 | Estimated | | Proportion of asymptomatic cases | | 85% | [2, 12, 16] | | Proportion of critical cases (C) that progress back to severe cases (H) | | 0.5 | [2, 12] | | Proportion of severe cases (H) that progress to critical cases (C) | | 0.302 | [12] | | Reciprocal of the average incubation period | | 0.196 | [12] | | Recovery proportion of asymptomatic cases (A) | | 1.0 | [12, 16] | | Recovery proportion of severe cases (H) | | 0.698 | [9, 12, 17] | | Recovery proportion of mild cases (M) | | 0.9815 | [12, 16] | | Proportion of mild cases (M) that progress to severe cases (H) | | 0.0185 | [12, 16] | | Proportion of fatalities of critical cases (C) | | 0.5 | [12, 18] |
|
|